Distinct methylation profiles of glioma subtypes
Authors:
Open Access
- 2 June 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 106 (1) , 52-59
Abstract
Gliomas are tumors of the central nervous system with a wide spectrum of different tumor types. They range from pilocytic astrocytoma, with a generally good prognosis, to the extremely aggressive malignant glioblastoma. In addition to these 2 types of contrasting neoplasms, several other subtypes can be distinguished, each characterized by specific phenotypic, as well as genotypic features. Recently, the epigenotype, as evident from differentially methylated DNA loci, has been proposed to be useful as a further criterion to distinguish between tumor types. In our study, we screened 139 tissue samples, including 33 pilocytic astrocytomas, 46 astrocytomas of different grades, 7 oligoastrocytomas, 10 oligodendrogliomas, 10 glioblastoma multiforme samples and 33 control tissues, for methylation at CpG islands of 15 different gene loci. We used the semiquantitative high throughput method MethyLight to analyze a gene panel comprising ARF, CDKN2B, RB1, APC, CDH1, ESR1, GSTP1, TGFBR2, THBS1, TIMP3, PTGS2, CTNNB1, CALCA, MYOD1 and HIC1. Seven of these loci showed tumor specific methylation changes. We found tissue as well as grade specific methylation profiles. Interestingly, pilocytic astrocytomas showed no evidence of CpG island hypermethylation, but were significantly hypomethylated, relative to control tissues, at MYOD1. Our results show that glioma subtypes have characteristic methylation profiles and, with the exception of pilocytic astrocytomas, show both locus specific hyper‐ as well as hypomethylation.Keywords
Funding Information
- the National Institutes of Health (NOI-HD-8-3284)
This publication has 18 references indexed in Scilit:
- Expression of various genes is controlled by DNA methylation during mammalian developmentJournal of Cellular Biochemistry, 2003
- Gliomagenesis: genetic alterations and mouse modelsNature Reviews Genetics, 2001
- DNA methylation in health and diseaseNature Reviews Genetics, 2000
- p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastomaOncogene, 2000
- Aberrant methylation of genes in low-grade astrocytomasBrain Tumor Pathology, 2000
- MethyLight: a high-throughput assay to measure DNA methylationNucleic Acids Research, 2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences, 1999
- Concordant methylation of the ER and N33 genes in glioblastoma multiformeOncogene, 1998
- A Modified and Improved Method for Bisulphite Based Cytosine Methylation AnalysisNucleic Acids Research, 1996